Nobuhito Sanada
Otsuka Pharmaceutical Co., Ltd.
11
0
1
N/A
0
6
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (11)
Showing 10 of 11 trials
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Michael B Gill
Power Life Sciences Inc.
Shared therapeutic areas:
Carlos A Zarate, M.D.
National Institute of Mental Health (NIMH)
Shared therapeutic areas:
Xinghua Gao
First Hospital of China Medical University
Shared therapeutic areas:
Areej El-Jawahri, MD
Massachusetts General Hospital
Shared therapeutic areas:
David Berk, MD
Arcutis Biotherapeutics, Inc.
Shared therapeutic areas:
Steven A Rosenberg, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Stanislaw R. Burzynski, MD, PhD
Burzynski Research Institute
Shared therapeutic areas:
Jean-Olivier ARNAUD, Director
Assistance Publique Hôpitaux de Marseille
Shared therapeutic areas:
John D. Hainsworth, MD
SCRI Development Innovations, LLC
Shared therapeutic areas:
Urielle Desalbres
Assistance Publique Hôpitaux de Marseille
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (11)
Showing 11 of 11 trials
A Long-term Administration Trial of SEP-363856 in Patients With Schizophrenia
A Long-term Trial of EB-1020 in Pediatric Patients With ADHD
A Trial to Evaluate the Efficacy and Safety of EB-1020 in Pediatric Patients With ADHD
A Long-term Trial of EB-1020 in Adult Patients With ADHD
Evaluation of the Efficacy and Safety of EB-1020 in Adult ADHD Patients
Safety and Efficacy Study of OPC-415 in Patients With Relapsed and/or Refractory Multiple Myeloma
A Phase I/II Study of ASTX660 in Patients With Relapsed or Refractory T-cell Lymphoma
A Phase 1 Trial of OPB-111077 in Combination With Bendamustine and Rituximab in Patients With r/r DLBCL
Phase 1 Trial of ASTX727 in Subjects With Lower-risk Myelodysplastic Syndromes
A Phase 3 Trial to Demonstrate the Superiority of 1% OPA-15406 Foam to the Vehicle in Adult Patients With Atopic Dermatitis
A Phase 3 Trial of OPA-15406 Foam in Children and Infants With Atopic Dermatitis
All 11 trials loaded